Harel Insurance Investments & Financial Services’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-493
Closed -$36K 745
2022
Q1
$36K Sell
493
-42
-8% -$2.92K ﹤0.01% 569
2021
Q4
$39K Buy
535
+201
+60% +$14.6K ﹤0.01% 624
2021
Q3
$26K Buy
+334
New +$26.8K ﹤0.01% 601
2020
Q3
Sell
-1,500
Closed -$72K 655
2020
Q2
$72K Buy
+1,500
New +$72.4K ﹤0.01% 359
2019
Q4
Sell
-1,000
Closed -$51K 503
2019
Q3
$51K Hold
1,000
﹤0.01% 303
2019
Q2
$42K Hold
1,000
﹤0.01% 335
2019
Q1
$49K Sell
1,000
-1,700
-63% -$76.9K ﹤0.01% 274
2018
Q4
$117K Buy
+2,700
New +$135K 0.01% 217

Other funds holding GMED

Harel Insurance Investments & Financial Services's GMED Position: Q2 2022 in Review

Harel Insurance Investments & Financial Services sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 493 shares — an estimated $36K sold.

Harel Insurance Investments & Financial Services first reported a position in GMED in Q4 2018 and held it in 8 quarters. The position peaked at $117K in Q4 2018. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • Harel Insurance Investments & Financial Services reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 493 Globus Medical shares in Q2 2022, an estimated $36K.
  • Harel Insurance Investments & Financial Services first reported a position in Globus Medical in Q4 2018 and held it in 8 quarters.
  • Harel Insurance Investments & Financial Services's Globus Medical position peaked at $117K in Q4 2018.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2022, filed 19 Jul 2022.